Afficher la couverture 'WED-455 Sex disparities in initiation of direct-acting antivirals for hepatitis C treatment: data from the French national healthcare database (2014–2022, ANRS FANTASIO 2 study) | Ramier, Clémence' en grand format
/5

0 avis

WED-455 Sex disparities in initiation of direct-acting antivirals for hepatitis C treatment: data from the French national healthcare database (2014–2022, ANRS FANTASIO 2 study)

Archive ouverte

Ramier, Clémence | Brouard, Cécile | Beo, Vincent Di | Allier, Yoann | Mourad, Abbas | Bureau, Morgane | Sogni, Philippe | Deuffic-Burban, Sylvie | Bourliere, Marc | Carrieri, Patrizia | Protopopescu, Camelia | Rolland, Benjamin | Marcellin, Fabienne

Edité par CCSD -

International audience.

BEFORE universal access to DAA AFTER universal access to DAA Characteristics (% of patients or median [interquartile range]) Men (N=59,883) Women (N=37,829) P-value Men (N=60,615) Women (N=37,171) P-value Age, in years 51 [44 -58] 57 [49 -67] <0.001 50 [41 -58] 56 [46 -67] <0.001 History of HCV treatment

Suggestions

Du même auteur

Hepatitis C treatment: Temporal and regional variations in the percentage of first-time prescriptions of direct-acting antivirals by general practitioners and associated factors, ANRS FANTASIO 2 project, mainland France, 2019–2022. Traitement de l’hépatite C : variations temporelles et régionales de la part des primo-prescriptions d’antiviraux à action directe par les médecins généralistes et facteurs associés, projet ANRS Fantasio 2, France hexagonale, 2019-2022

Archive ouverte | Marcellin, Fabienne | CCSD

International audience. Introduction – In May 2019, first prescription of direct-acting antivirals (DAA) for treatment of hepatitis C, initially reserved for specialists practicing in hospitals, was extended to all ...

Cannabis Use Is Inversely Associated with Overweight and Obesity in Hepatitis B Virus-Infected Patients (ANRS CO22 Hepather Cohort)

Archive ouverte | Barré, Tangui | CCSD

International audience. Background: Chronic hepatitis B virus (HBV) infection may evolve into cirrhosis and hepatocellular carcinoma, and this progression may be accelerated by specific risk factors, including overw...

Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

Archive ouverte | Barré, Tangui | CCSD

International audience. Background: Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is a major risk factor for these disorders, and therefore, m...

Chargement des enrichissements...